MedPath

An early tailored cognitive behavioural therapy intervention for depression in individuals newly diagnosed with multiple sclerosis

Not Applicable
Completed
Conditions
Mild to moderate depression among individuals newly diagnosed with MS
Mental and Behavioural Disorders
Registration Number
ISRCTN63987586
Lead Sponsor
Multiple Sclerosis Research Australia
Brief Summary

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31959224 protocol (added 22/01/2020)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60
Inclusion Criteria

1. Mild to moderately depressed patients with MS
2. Diagnosed with MS within the last 5 years and are considered newly diagnosed.
3. Adult (i.e., 18-65 years old)

Exclusion Criteria

1. Gross cognitive impairment that would make participation in the 8 one hour sessions of Cognitive Behavioural Therapy distressing
2. Unable to speak or read English
3. Acute organic brain syndrome (e.g., delirium)
4. Serious psychological disorder (e.g., psychosis)
5. Assessed with the BDI-II and the SCID-5 as being severely depressed
6. Already undertaking psychological treatment for depression/anxiety
7. Taking antidepressants for less than two months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath